CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced that the company has been added to the Russell 2000 and 3000 indexes following the Russell U.S. Indexes’ quarterly update. The Russell 3000 index includes the 3,000 largest U.S. companies by market capitalization. Membership in the Russell 3000® Index means automatic inclus
